34 results
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
. FDA may hold a public hearing where an independent advisory committee of expert advisors asks additional questions and makes recommendations
424B5
SLNO
Soleno Therapeutics Inc
27 Sep 23
Prospectus supplement for primary offering
5:26pm
(NDA) with FDA. FDA may hold a public hearing where an independent advisory committee of expert advisors asks additional questions and makes
424B5
qcrowo935jzzi
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
5zhsk5lxuxkh43ob
28 Mar 22
Prospectus supplement for primary offering
4:53pm
424B5
wiiuu1dm3kqbw6
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
c57ntj
23 Jun 20
Prospectus supplement for primary offering
4:06pm
424B5
3wlym
25 Oct 19
Prospectus supplement for primary offering
12:00am